BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer
Sun Min Lim(Yonsei University), Sang-Yoon Lee(ABL Bio (South Korea))
Cited by 72
Related Papers
Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme
|PLoS ONE|2015|6